Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond-Reference-Cited by-同舟云学术

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond

Published:2017-08-17 Issue:11 Volume:39 Page:2329-2349
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

de Bree Remco¹^ORCID,Wolf Gregory T.²,de Keizer Bart³,Nixon Iain J.⁴^ORCID,Hartl Dana M.⁵⁶,Forastiere Arlene A.⁷,Haigentz Missak⁸,Rinaldo Alessandra⁹,Rodrigo Juan P.¹⁰¹¹,Saba Nabil F.¹²^ORCID,Suárez Carlos¹¹¹³,Vermorken Jan B.¹⁴,Ferlito Alfio¹⁵

Affiliation:

1. Department of Head and Neck Surgical Oncology; UMC Utrecht Cancer Center, University Medical Center Utrecht; Utrecht The Netherlands

2. Department of Otolaryngology-Head and Neck Surgery; University of Michigan Health System; Ann Arbor Michigan

3. Department of Radiology and Nuclear Medicine; University Medical Center Utrecht; Utrecht The Netherlands

4. Ear, Nose, and Throat Department, NHS Lothian; Edinburgh UK

5. Department of Otolaryngology - Head and Neck Surgery; Institut Gustave Roussy; Villejuif Cedex France

6. Laboratoire de Phonétique et de Phonologie; Sorbonne Nouvelle; Paris France

7. Department of Oncology; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine; Baltimore Maryland

8. Department of Medicine; Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center; Bronx New York

9. University of Udine School of Medicine; Udine Italy

10. Instituto Universitario de Oncología del Principado de Asturias; University of Oviedo; Oviedo Spain

11. Department of Otolaryngology; Hospital Universitario Central de Asturias; Oviedo Spain

12. Department of Hematology and Medical Oncology; The Winship Cancer Institute of Emory University; Atlanta Georgia

13. Fundación de Investigación e Innovación Biosanitaria del Principado de Asturias; Oviedo Spain

14. Department of Medical Oncology; Antwerp University Hospital; Edegem Belgium

15. Coordinator of the International Head and Neck Scientific Group

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.24883/fullpdf

Reference72 articles.

1. High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial;Tarpley;Am J Surg.,1975

2. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders;Laccourreye;Cancer.,2001

3. Chemotherapy alone for glottic carcinoma: a need for higher-level evidence;Hartl;Ann Otol Rhinol Laryngol.,2009

4. The future of induction chemotherapy for head and neck squamous cell carcinoma;Haigentz;Oral Oncol.,2012

5. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol.,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer;International Journal of Molecular Sciences;2023-12-22

2. Machine Learning-Based MRI Radiogenomics for Evaluation of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma;Academic Radiology;2023-11

3. Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?;Critical Reviews in Oncology/Hematology;2023-06

4. Role of Post-Treatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients Receiving Definitive Chemoradiation for Locally Advanced Head and Neck Squamous Cell Carcinomas;Korean Journal of Otorhinolaryngology-Head and Neck Surgery;2022-11-21

5. A novel 3D pillar/well array platform using patient-derived head and neck tumor to predict the individual radioresponse;Translational Oncology;2022-10